Skip to content

Esophagus

Anatomy & Physiology

Paraesophageal Hernias

Etiology and Management of Esophageal Perforation

Management of Esophageal Perforations and Leaks

Submucosal Tumors (SMTs) of the Esophagus and Gastroesophageal Junction (GEJ)

[Revision Notes: Robotic Ivor-Lewis Esophagectomy (RAMIE)](Esophagus%206012a709f6fc4ea8a92a121868891836/Revision%20Notes%20Robotic%20Ivor-Lewis%20Esophagectomy%20(R%2011c26680bfb980abb436dc2a7e08664a.md)

Caustic Esophageal Injury Revision Notes [SKF 47]

Etiology and Management of Esophageal Perforation & Leaks [SKF 48& 49]

Extent of Lymphadenectomy for Esophageal Cancer

Options for Esophageal Replacement

Anastomotic Complications After Esophagectomy: Frequency, Prevention, and Management [43 SKF]

Sphincter, Body, Mucosa in Health and Disease

Relevant Anatomic Relations of the Esophagus

Speed Live Classes

Motor Disorders of Esophagus

GERD

Syndromes associated with Esophageal Cancer:

  1. Peutz jegger Sx = EAC
  2. PTEN Hamartoma Sx = EAC
  3. HPV = SCC
  4. Tylosis =SCC
  5. Howel Evans Sx =SCC

KEYNOTE 181 Trial = Pembrolizumab Monotherapy [Immunotherapy] in Esophageal SCC

image.png

image.png

Here is a detailed breakdown and revision note based on the Intraepithelial Papillary Capillary Loop (IPCL) classification system by H Inoue (2001) and the Japanese Esophageal Society (JES) classification (2017):


IPCL Classification by H Inoue (2001)

This classification is based on Intraepithelial Papillary Capillary Loops (IPCLs), which are capillaries visible under magnification endoscopy. They are used to assess tissue characteristics and the depth of cancer infiltration. The classification ranges from Type I to Type V-N, progressively indicating more severe capillary abnormalities and deeper cancer infiltration.

IPCL Type I

  • Appearance: Regular IPCL with minimal or no abnormalities.
  • Tissue Characteristic: Normal flat lesions.
  • Cancer Infiltration Depth: None.
  • Indication: No intervention required.

IPCL Type II

  • Appearance: Slight irregularity in capillary caliber and formation.
  • Tissue Characteristic: Slight changes in flat lesions.
  • Cancer Infiltration Depth: None.
  • Indication: Observation or non-invasive follow-up.

IPCL Type III

  • Appearance: Increased irregularity in capillary structure.
  • Tissue Characteristic: More pronounced changes in flat lesions.
  • Cancer Infiltration Depth: None.
  • Indication: Possible biopsy and further evaluation.

IPCL Type IV

  • Appearance: Marked irregularity with meandering, dilated vessels.
  • Tissue Characteristic: Flat lesions showing tissue changes with more invasive potential.
  • Cancer Infiltration Depth: Superficial mucosal invasion.
  • Indication: Endoscopic Mucosal Resection (EMR) or Endoscopic Submucosal Dissection (ESD) may be considered.

IPCL Type V

This group is further subdivided based on the depth of cancer invasion and the extent of IPCL abnormality:

  • IPCL Type V-1 (m1):
    • Appearance: Dilated, meandering, irregular caliber, and form variation of IPCL.
    • Cancer Infiltration Depth: Mucosal layer (superficial).
    • Indication: EMR/ESD indicated.
  • IPCL Type V-2 (m2):
    • Appearance: Extension of IPCL abnormalities from V-1.
    • Cancer Infiltration Depth: Mucosal layer, deeper than V-1.
    • Indication: EMR/ESD with caution; surgical resection may be needed depending on depth.
  • IPCL Type V-3 (m3, sm1, or deeper):
    • Appearance: Advanced destruction of IPCL structure, indicating significant abnormality.
    • Cancer Infiltration Depth: Submucosal invasion (sm1 or deeper).
    • Indication: Surgical treatment is generally required due to the depth of invasion.
  • IPCL Type V-N (sm2 or deeper):
    • Appearance: Generation of new tumor vessels, highly abnormal structure.
    • Cancer Infiltration Depth: Deep submucosal invasion.
    • Indication: Surgical resection due to advanced cancer invasion.

Japanese Esophageal Society (JES) Classification (2017)

This system provides a simplified classification for esophageal lesions, particularly focusing on abnormalities of microvessels. The JES classification correlates well with the depth of invasion as described in the IPCL classification.

JES Type A

  • Appearance: Normal or minimally abnormal IPCLs, without severe irregularity.
  • Indication: No immediate treatment required; observation.

JES Type B1

  • Appearance: Abnormal microvessels with significant irregularity, often associated with highly dilated vessels or loop-like formations.
  • Indication: EMR/ESD may be considered based on depth and involvement.

JES Type B2

  • Appearance: Abnormal vessels (Type B), but without the loop-like formation.
  • Indication: Further investigation and potential endoscopic treatment depending on depth.

JES Type B3

  • Appearance: Highly dilated vessels with calibers three times the size of normal B2 vessels.
  • Indication: Likely indicates advanced invasion and requires surgical intervention.

Summary of Treatment Indications:

  • IPCL Types I-III & JES Type A: Observation, non-invasive management.
  • IPCL Type V-1, V-2 & IV & JES Type B1: EMR/ESD strongly considered due to early invasion risk.
  • IPCL Type V-3,JES Type B2: Relative indication for EMR/ESD, with surgery possible if invasion is deep.
  • IPCL Type0 V-N & JES Type B3: Surgical treatment necessary due to deep tissue invasion and highly abnormal capillary patterns.

This classification aids in determining the depth of invasion, the risk of malignancy, and the appropriate intervention, ranging from simple observation to surgical treatment based on the IPCL and JES categories.